Showing results (391-400 of 532) with videos related to

Sort By:
Pageof 54
Clinical Transplantation|April 1, 2021
Donation after circulatory death liver transplantation: An in-depth analysis and propensity score-matched comparisonMark J Hobeika, Ashish Saharia, Constance M Mobley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2008
Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemiaAldo M Roccaro, Xavier Leleu, Antonio Sacco, et al.
Annals of Surgery|September 2, 2005
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL ConsortiumKim M Olthoff, Robert M Merion, Rafik M Ghobrial, et al.
British Journal of Haematology|June 10, 2008
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemiaAnne-Sophie Moreau, Xiaoying Jia, Christopher J Patterson, et al.
Nanoscale|October 26, 2019
Antibody-targeting of ultra-small nanoparticles enhances imaging sensitivity and enables longitudinal tracking of multiple myelomaAlexandre Detappe, Mairead Reidy, Yingjie Yu, et al.
Mayo Clinic Proceedings|February 13, 2004
Therapeutic options in patients with lymphoma and severe liver dysfunctionIrene M Ghobrial, Robert C Wolf, Denise L Pereira, et al.
Annals of Surgery|August 29, 2001
A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patientsR M Ghobrial, R Steadman, J Gornbein, et al.
Blood|April 30, 2009
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myelomaAldo M Roccaro, Antonio Sacco, Brian Thompson, et al.
Blood|December 17, 2008
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemiaAldo M Roccaro, Antonio Sacco, Changzhong Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myelomaLanie K Francis, Yazan Alsayed, Xavier Leleu, et al.
Pageof 54